{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:08:44Z","timestamp":1758935324050},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,31]]},"DOI":"10.7759\/cureus.61470","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T06:03:33Z","timestamp":1717221813000},"source":"Crossref","is-referenced-by-count":1,"title":["The Utility and Limitations of Universal Polymerase Chain Reaction Screening for SARS-CoV-2 During Hospital Admission"],"prefix":"10.7759","author":[{"given":"Naruhiko","family":"Ogo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ikegame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taeko","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Kan-o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuto","family":"Yoneshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Tsubouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isamu","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou P","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, et al.. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020, 579:270-3. 10.1038\/s41586-020-2012-7","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01047-0","article-title":"The reproduction rate of severe acute respiratory syndrome coronavirus 2 different variants recently circulated in human: a narrative review","volume":"28","author":"Karimizadeh Z","year":"2023","unstructured":"Karimizadeh Z, Dowran R, Mokhtari-Azad T, Shafiei-Jandaghi NZ. The reproduction rate of severe acute respiratory syndrome coronavirus 2 different variants recently circulated in human: a narrative review. Eur J Med Res. 2023, 28:94. 10.1186\/s40001-023-01047-0","journal-title":"Eur J Med Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack FP","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, et al.. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020, 383:2603-15. 10.1056\/NEJMoa2034577","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson EJ","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, et al.. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020, 584:430-6. 10.1038\/s41586-020-2521-4","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.surge.2021.04.007","article-title":"IMPACT of COVID-19 on hip fracture services: a global survey by the International Multicentre Project Auditing COVID-19 in Trauma & Orthopaedics","volume":"20","author":"Hall AJ","year":"2022","unstructured":"Hall AJ, Clement ND, MacLullich AM, et al.. IMPACT of COVID-19 on hip fracture services: a global survey by the International Multicentre Project Auditing COVID-19 in Trauma & Orthopaedics. Surgeon. 2022, 20:237-40. 10.1016\/j.surge.2021.04.007","journal-title":"Surgeon"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2021.104915","article-title":"Universal polymerase chain reaction screening for severe acute respiratory syndrome coronavirus 2 in asymptomatic patients before hospital admission in Tokyo, Japan","volume":"142","author":"Uchida S","year":"2021","unstructured":"Uchida S, Uwamino Y, Uno S, et al.. Universal polymerase chain reaction screening for severe acute respiratory syndrome coronavirus 2 in asymptomatic patients before hospital admission in Tokyo, Japan. J Clin Virol. 2021, 142:104915. 10.1016\/j.jcv.2021.104915","journal-title":"J Clin Virol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2020.12.009","article-title":"Polymerase-chain reaction testing to prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection in Shinjuku, an epicenter in Tokyo: the Tokyo Women's Medical University model","volume":"59","author":"Arimura K","year":"2021","unstructured":"Arimura K, Tagaya E, Kikuchi K, et al.. Polymerase-chain reaction testing to prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection in Shinjuku, an epicenter in Tokyo: the Tokyo Women's Medical University model. Respir Investig. 2021, 59:356-9. 10.1016\/j.resinv.2020.12.009","journal-title":"Respir Investig"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0277426","article-title":"Universal admission screening for COVID-19 using quantitative antigen testing and questionnaire screening to prevent nosocomial spread","volume":"17","author":"Morishima M","year":"2022","unstructured":"Morishima M, Kimura M, Sakoh T, et al.. Universal admission screening for COVID-19 using quantitative antigen testing and questionnaire screening to prevent nosocomial spread. PLoS One. 2022, 17:e0277426. 10.1371\/journal.pone.0277426","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16353","article-title":"SARS-CoV-2 viral dynamics in immunocompromised patients","volume":"21","author":"Caillard S","year":"2021","unstructured":"Caillard S, Benotmane I, Gautier Vargas G, Perrin P, Fafi-Kremer S. SARS-CoV-2 viral dynamics in immunocompromised patients. Am J Transplant. 2021, 21:1667-9. 10.1111\/ajt.16353","journal-title":"Am J Transplant"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(23)00286-0","article-title":"Performance of SARS-CoV-2 nucleic acid amplification testing in Austria as measured by external quality assessment schemes during 3 years of the COVID-19 pandemic: an observational retrospective study","author":"Buchta C","year":"20234","unstructured":"Buchta C, Aberle SW, Allerberger F, et al.. Performance of SARS-CoV-2 nucleic acid amplification testing in Austria as measured by external quality assessment schemes during 3 years of the COVID-19 pandemic: an observational retrospective study. Lancet Microbe. 20234, 1015-23. 10.1016\/S2666-5247(23)00286-0","journal-title":"Lancet Microbe"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00075-21","article-title":"SARS-CoV-2 E gene variant alters analytical sensitivity characteristics of viral detection using a commercial reverse transcription-PCR assay","volume":"59","author":"Tahan S","year":"2021","unstructured":"Tahan S, Parikh BA, Droit L, Wallace MA, Burnham CD, Wang D. SARS-CoV-2 E gene variant alters analytical sensitivity characteristics of viral detection using a commercial reverse transcription-PCR assay. J Clin Microbiol. 2021, 59:e0007521. 10.1128\/JCM.00075-21","journal-title":"J Clin Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00600-22","article-title":"Partial ORF1ab gene target failure with Omicron BA.2.12.1","volume":"60","author":"Rodino KG","year":"2022","unstructured":"Rodino KG, Peaper DR, Kelly BJ, et al.. Partial ORF1ab gene target failure with Omicron BA.2.12.1. J Clin Microbiol. 2022, 60:e0060022. 10.1128\/jcm.00600-22","journal-title":"J Clin Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118691","article-title":"Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection","volume":"386","author":"Hall V","year":"2022","unstructured":"Hall V, Foulkes S, Insalata F, et al.. Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection. N Engl J Med. 2022, 386:1207-20. 10.1056\/NEJMoa2118691","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2031670","article-title":"Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer","volume":"383","author":"Aydillo T","year":"2020","unstructured":"Aydillo T, Gonzalez-Reiche AS, Aslam S, et al.. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer. N Engl J Med. 2020, 383:2586-8. 10.1056\/NEJMc2031670","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00855-21","article-title":"Prolonged SARS-CoV-2 positivity in immunocompetent patients: virus isolation, genomic integrity, and transmission risk","volume":"9","author":"Leit\u00e3o IC","year":"2021","unstructured":"Leit\u00e3o IC, Calil PT, Galliez RM, et al.. Prolonged SARS-CoV-2 positivity in immunocompetent patients: virus isolation, genomic integrity, and transmission risk. Microbiol Spectr. 2021, 9:e0085521. 10.1128\/Spectrum.00855-21","journal-title":"Microbiol Spectr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25908-6","article-title":"Reinfection rate in a cohort of healthcare workers over 2\u00a0years of the COVID-19 pandemic","volume":"13","author":"Guedes AR","year":"2023","unstructured":"Guedes AR, Oliveira MS, Tavares BM, et al.. Reinfection rate in a cohort of healthcare workers over 2\u00a0years of the COVID-19 pandemic. Sci Rep. 2023, 13:712. 10.1038\/s41598-022-25908-6","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2022.112911","article-title":"SARS-CoV-2 reinfections: overview of efficacy and duration of natural and hybrid immunity","volume":"209","author":"Pilz S","year":"2022","unstructured":"Pilz S, Theiler-Schwetz V, Trummer C, Krause R, Ioannidis JP. SARS-CoV-2 reinfections: overview of efficacy and duration of natural and hybrid immunity. Environ Res. 2022, 209:112911. 10.1016\/j.envres.2022.112911","journal-title":"Environ Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2023.01.025","article-title":"Factors associated with post-treatment control of viral load in HIV-infected patients: a systematic review and meta-analysis","volume":"129","author":"Zhou C","year":"2023","unstructured":"Zhou C, Wu Y, Zhang Y, et al.. Factors associated with post-treatment control of viral load in HIV-infected patients: a systematic review and meta-analysis. Int J Infect Dis. 2023, 129:216-27. 10.1016\/j.ijid.2023.01.025","journal-title":"Int J Infect Dis"},{"key":"ref19","unstructured":"About SARS-CoV-2 variants (historical data). (2024). Accessed. May 28, 2024: https:\/\/www.niid.go.jp\/niid\/ja\/from-lab\/488-flu\/12054-flu2-1-2.html."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2023.0059","article-title":"Accuracy of rapid antigen screening tests for SARS-CoV-2 infection at correctional facilities in Korea: March-May 2022","volume":"55","author":"Lee HY","year":"2023","unstructured":"Lee HY, Park YJ, Yu M, et al.. Accuracy of rapid antigen screening tests for SARS-CoV-2 infection at correctional facilities in Korea: March-May 2022. Infect Chemother. 2023, 55:460-70. 10.3947\/ic.2023.0059","journal-title":"Infect Chemother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/256854-the-utility-and-limitations-of-universal-polymerase-chain-reaction-screening-for-sars-cov-2-during-hospital-admission","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T06:03:36Z","timestamp":1717221816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/256854-the-utility-and-limitations-of-universal-polymerase-chain-reaction-screening-for-sars-cov-2-during-hospital-admission"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.61470","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,31]]}}}